Navigation Links
China Medicine Announces Changes to Management Team
Date:12/23/2009

GUANGZHOU, China, Dec. 23 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a developer and leading distributor of prescription and over the counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, and medical devices and medical formulations, today announced that Richard P. Wu has resigned as Chief Financial Officer in order to pursue other professional interests. His resignation was effective December 15, 2009.

Mr. Robert Lu was appointed to serve as the Company's Interim Chief Financial Officer until the Company selected a permanent Chief Financial Officer.

Robert Lu has served as the Company's Financial Manager since August 6, 2009. Prior to joining the Company, Mr. Lu served as the International Regional Tax Manager of Hua Wei Technologies Co., Ltd. from October 2006 through August 2009. From August 2003 to September 2006, Mr. Lu served as a financial supervisor for Dongguan Pulse Electronics Co., Ltd. Mr. Lu received his Bachelor's degree in accounting from the Harbin Institute of Technology in 2003. Mr. Lu is a member of the Chinese Institute of Certified Public Accountants (CICPA) and is fluent in English. He will be supported by Ms. Huizhen Yu, the Company's controller.

"We wish Mr. Wu well in his future endeavors and expect a smooth transition of his responsibilities to Mr. Lu, who has been involved with our cash planning, internal and external reporting and tax planning and capital budgeting for the last several months. We will seek to improve our financial management team with a permanent CFO in the months ahead," stated Mr. Senshan Yang, Chairman and CEO of China Medicine Corporation.

About China Medicine Corporation

China Corporation is a developer and leading distributor of prescription and over the counter ("OTC") drugs, traditional C
'/>"/>

SOURCE China Medicine Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Today, the world,s largest and fastest provider ... more transparent, the importance of websites continues to grow ... maxim of "innovation brings progress and changes thinking" will ... The company has long been recognised as an international ... and modern approach, while also repeatedly breaking new ground ...
(Date:6/2/2015)... June 2, 2015  University Hospitals (UH) ... Cleveland area to implant a new miniaturized, ... HF System is the first and only FDA-approved heart failure ... admissions when used by physicians to manage heart failure., ... that is implanted in the pulmonary artery (PA) during a ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/d8nj6b/europe ) has announced ... Growth, Trends And Forecasts (2014 - 2019)" report ... Fluoroscopy is expected to grow at a healthy CAGR ... to view the gastrointestinal tract, to direct the movement ... the urinary system, to open narrowed or blocked blood ...
Breaking Medicine Technology:UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 2UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 3European Fluoroscopy Market Report 2014-2019 - Growth, Trends And Forecasts 2
... , EAST HANOVER, N.J. , June 3 ... III study of Afinitor® (everolimus) tablets plus best supportive care ... survival, or time without tumor growth, in patients with advanced ... I n A dvanced N euroendocrine ...
... Today, the U.S. Food and Drug Administration (FDA) released final ... a long-acting beta-agonist (LABA).  This follows the FDA communication on 18 ... changes. , , , ... http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) , , ...
Cached Medicine Technology:Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 2Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 3Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 4Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 5Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 6Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 7FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 2FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 3FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 4FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 5FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 6
(Date:6/3/2015)... 03, 2015 Come on out in ... a 200-mile overnight relay beginning in Madison, Wisconsin on ... Saturday, June 13th. , For the 4th consecutive year, ... will run to raise money for the Brain Aneurysm ... members of the Neurosurgery staff from The University of ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Unfortunately, a majority ... it comes to providing comfort to the users throughout the ... brand or one from the local market, the makers generally ... and, in the process, often overlook comfort and health. To ... of shoe, the creative heads at Vay Technologies have come ...
(Date:6/3/2015)... Israel (PRWEB) June 03, 2015 evigilo, ... multi-channel solutions, has showcased its new branding by launching ... , "The new brand identity: the logo depicting ... red, to green, the tagline – To Know. To ... new path evigilo is charting. A global, borderless approach ...
(Date:6/2/2015)... June 02, 2015 Allred Dental, a dental ... for the months June-September, 2015 along with a $100 off ... limited time only. , “Sometimes wisdom teeth can be impacted, ... jawbone. They can also only partially break through the gum, ... recovery is easier in young people, as they do not ...
(Date:6/2/2015)... Pleasant Prairie, WI (PRWEB) June 03, 2015 ... suited for regulated industries such as government, finance and ... any organization that wants reliable access control to enhance ... smart card keyboard requires the secondary authentication of a ... In addition to the smart-chipset card reader, the ...
Breaking Medicine News(10 mins):Health News:4th Annual Ragnar Relay from Madison, WI to Chicago, IL Once Again Benefits Renowned Brain Aneurysm Foundation 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 3Health News:Keep calm! evigilos' "sun" will come out tomorrow – to know, to act, in time. 2Health News:$100 Off Coupon for Wisdom Teeth Extractions Offered at Allred Dental 2Health News:Introducing the New CHERRY JK-A0100EU Keyboard with Integrated Smart Card Reader for Access Control Security 2
... March 18 Askesis Development Group, Inc., a ... addictions treatment, and social services markets, is pleased ... and enhanced features are focused on creating a ... a comprehensive electronic medical record (EMR), and streamlined ...
... of certain cytokines spiked during disease stage , , WEDNESDAY, ... recently had the rare opportunity to follow the West ... in a 29-year-old lab worker who had accidentally jabbed ... researchers followed the trajectory of cytokines, a type of ...
... Institute of Technology are opening a new center that ... resonance imaging scanner to further study into the mysteries ... Advanced Brain Imaging, a joint venture of Georgia State ... topics from autism and learning disabilities, to applied physiology, ...
... disease recurrence, death nearly twice that of normal-weight patients ... cancer patients are more likely than non-obese patients to ... say U.S. researchers. , "We identified a subset ... at 12-fold increased risk of lymph node metastasis compared ...
... CEO until Executive Search for Replacement is CompletedPlanned ... 2009 at 4:15 PM ET LIVINGSTON, N.J., ... Board: MLSS), the recognized leader in advanced injection ... the Board, will temporarily assume the post of ...
... 18 The American Academy of Nurse Practitioners (AANP) ... position of AANP Chief Executive Officer, effective March 20, ... FAANP, who will retire after 13 years as CEO ... will continue in her role as Executive Director of ...
Cached Medicine News:Health News:Askesis Development Group, Inc. Launches New Behavioral Health Software for Electronic Medical Records (EMR) and Practice Management 2Health News:Course of West Nile Infection Charted 2Health News:Course of West Nile Infection Charted 3Health News:Georgia State/Georgia Tech Center for Advanced Brain Imaging to expand brain, mind research 2Health News:Obesity Tied to Poor Pancreatic Cancer Surgery Outcomes 2Health News:Milestone Scientific Announces Resignation of CEO 2Health News:Milestone Scientific Announces Resignation of CEO 3Health News:American Academy of Nurse Practitioners Announces New Chief Executive Officer 2
Spectra 3000RS & Spectra 3000RSP are very precise instruments. They have a metal base structure, durable parts for long life use, and they are very easy to use and maintain....
... Series Spectrophotometer is truly ... UV-VIS instrumentation. The latest ... into a radically new ... and performance unprecedented in ...
... the user to quickly and accurately count bacteria ... counting or manual counting. An optional 1.5X auxiliary ... to 3.0X. The adjustable focusing rod allows the ... The lens also rotates a full 360 for ...
The Accucount 2000 is designed to automatically count microscopic objects in a field displaying totals on a highly visible digital readout....
Medicine Products: